Grant: Idea to Innovation
University of Waterloo
$15,000.00
Cortical challenge and recovery test (CCaRT): Market assessment for an rTMS-based cognitive assessment system.
FY 2020-21
Summary
CCaRT is a cognitive assessment system comprising protocols, software and apparatus for the assessment of three important parameters of brain health: 1) cortical resilience 2) unidirectional cortical plasticity, and 3) bidirectional cortical plasticity. CCaRT is innovative in that is uses transcranial magnetic stimulation (rTMS) interleaved with cognitive testing and functional near-infrared spectroscopy (fNIRS) to produce new parameters of brain health that are not currently derived from any other assessment on the market. The paradigm involves cognitive testing before and after brain stimulation to quantify the initial suppression effect followed by subsequent time-locked measurements of recovery. This novel metric can provide meaningful information by constructing a normative database with which to compare the percentage value generated. Interpretive reports prepared via cloud based on this metric will provide more value particularly in clinical settings. Currently, there are no other solutions that can identify a brain health parameter that is not already routinely assessed. Waterloo's technology is the first to make use of rTMS for identifying this specific brain health parameter (cortical resilience). The diagnostic potential of CCaRT is substantial in relation to neurological and psychiatric disorders that affect the brain, and there are numerous research applications. Advantages of Waterloo's technology include: (1) brain health assessment with norm-referenced outcome comparison, (2) semi-automated cognitive assessment, and (3) well suited to clinical settings where services are billed, or in clinical research contexts (e.g., clinical trials, longitudinal studies). As part of this Market Assessment grant, the selected consultant (Adventus) will perform a thorough market analysis to identify the most suitable market opportunities along with technical, marketing and financial challenges associated with the application of the technology in a particular market segment. A favorable market assessment result will 1) formulate the commercialization strategy and help attract potential licensees 2) form the basis for submitting a follow-on NSERC I2I Phase 1 project proposal.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
556916-2020
Name nom
Hall, Peter
Department département
Public Health and Health Systems, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6307
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Cognitive science -- other
Research subject fr
Science cognitive -- autres
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Cortical challenge and recovery test (CCaRT): Market assessment for an rTMS-based cognitive assessment system.
Keyword
NSERC
Application summary
CCaRT is a cognitive assessment system comprising protocols, software and apparatus for the assessment of three important parameters of brain health: 1) cortical resilience 2) unidirectional cortical plasticity, and 3) bidirectional cortical plasticity. CCaRT is innovative in that is uses transcranial magnetic stimulation (rTMS) interleaved with cognitive testing and functional near-infrared spectroscopy (fNIRS) to produce new parameters of brain health that are not currently derived from any other assessment on the market. The paradigm involves cognitive testing before and after brain stimulation to quantify the initial suppression effect followed by subsequent time-locked measurements of recovery. This novel metric can provide meaningful information by constructing a normative database with which to compare the percentage value generated. Interpretive reports prepared via cloud based on this metric will provide more value particularly in clinical settings. Currently, there are no other solutions that can identify a brain health parameter that is not already routinely assessed. Waterloo's technology is the first to make use of rTMS for identifying this specific brain health parameter (cortical resilience). The diagnostic potential of CCaRT is substantial in relation to neurological and psychiatric disorders that affect the brain, and there are numerous research applications. Advantages of Waterloo's technology include: (1) brain health assessment with norm-referenced outcome comparison, (2) semi-automated cognitive assessment, and (3) well suited to clinical settings where services are billed, or in clinical research contexts (e.g., clinical trials, longitudinal studies). As part of this Market Assessment grant, the selected consultant (Adventus) will perform a thorough market analysis to identify the most suitable market opportunities along with technical, marketing and financial challenges associated with the application of the technology in a particular market segment. A favorable market assessment result will 1) formulate the commercialization strategy and help attract potential licensees 2) form the basis for submitting a follow-on NSERC I2I Phase 1 project proposal.